Overview

• He says he will start the event’s medical protocol in 2026 after clinical testing that yields individualized medication recommendations.
• The permitted substances are FDA‑approved products such as anabolic agents, testosterone and growth hormone, with dosages presented as physician suggestions.
• Organizers plan to track athletes’ biomarkers for five years after the competition.
• Kusch cites financial incentives as a key motive, highlighting prize money, appearance fees, a salary, budgets for personal doctors and new insurance coverage.
• The inaugural edition is slated for May 2026 in Las Vegas with swimming, athletics and weightlifting, and he is the first German to commit, drawing continued criticism from German sport bodies.